Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PDZRN3
is a PDZ domain-containing RING-finger family protein that functions in various developmental processes. We previously showed that expression of
PDZRN3
is induced together with that of MyoD during the early phase of skeletal muscle regeneration in vivo. We here show that
PDZRN3
suppresses apoptosis and promotes proliferation in myoblasts in a manner dependent on cyclin A2. Depletion of
PDZRN3
in mouse C2C12 myoblasts by RNA interference reduced the proportion of Ki-67-positive cells and the level of Akt phosphorylation, implicating
PDZRN3
in regulation of both cell proliferation and apoptosis. Exposure of C2C12 cells as well as of C3H10T1/2 mesenchymal stem cells and NIH-3T3 fibroblasts to various inducers of apoptosis including serum deprivation resulted in a greater increase in the amount of cleaved
caspase-3
in
PDZRN3
-depleted cells than in control cells. The abundance of cyclin A2 was reduced in
PDZRN3
-depleted C2C12 myoblasts, as was that of Mre11, which contributes to the repair of DNA damage. Overexpression of cyclin A2 restored the expression of Mre11 and Ki-67 as well as attenuated
caspase-3
cleavage in
PDZRN3
-depleted cells deprived of serum. These results indicate that
PDZRN3
suppresses apoptosis and promotes proliferation in myoblasts and other cell types by maintaining cyclin A2 expression.
...
PMID:PDZRN3 protects against apoptosis in myoblasts by maintaining cyclin A2 expression. 3198 Jul 7